A6541512
Olanzapine , ≥99% , 132539-06-1
Synonym(s):
2-Methyl-4-(4-methyl-1-piperazinyl)- 10H-thieno[2,3-b][1,5]benzodiazepine;LY-170053;Olanzapine
CAS NO.:132539-06-1
Empirical Formula: C17H20N4S
Molecular Weight: 312.43
MDL number: MFCD00866702
EINECS: 603-618-4
Pack Size | Price | Stock | Quantity |
1G | RMB71.20 | In Stock |
|
5G | RMB215.20 | In Stock |
|
25g | RMB742.40 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 195°C |
Boiling point: | 476.0±55.0 °C(Predicted) |
Density | 1.32±0.1 g/cm3(Predicted) |
Flash point: | 2℃ |
storage temp. | 2-8°C |
solubility | DMSO: >15mg/mL |
form | powder |
pka | 7.78±0.20(Predicted) |
color | yellow |
Merck | 14,6822 |
BRN | 7655141 |
BCS Class | 2 |
CAS DataBase Reference | 132539-06-1(CAS DataBase Reference) |
NIST Chemistry Reference | Olanzapine(132539-06-1) |
Description and Uses
O lanzapine is classed as an atypical antipsychotic and is considered a firstline agent in the management of newly diagnosed psychosis. It has a similar mechanism of action to classical antipsychotics but with a lower incidence of adverse events. O lanzapine rarely produces hypotension and has less potential for QT prolongation. It is used in the management of delirium in ICU.
intermediate for Imidacloprid, Indobufen, Nitroguanidine, Nalorphine, Tazarotene, Trovafloxacin
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319 |
Precautionary statements | P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313 |
Hazard Codes | Xi,Xn,F |
Risk Statements | 36/38-36-20/21/22-11 |
Safety Statements | 26-36/37-16 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | 3 |
RTECS | XJ9007750 |
HazardClass | 6.1 |
PackingGroup | III |
HS Code | 29349990 |
Hazardous Substances Data | 132539-06-1(Hazardous Substances Data) |
Toxicity | human,TDLo,oral,16560ug/kg/12 (16.56mg/kg),Journal of Clinical Psychiatry. Vol. 60, Pg. 767, 1999. |